DRTSAlpha Tau Medical Ltd. Ordinary Shares
14.92USDMkt Cap: 1.38B $P/E: —3d ago
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid ca…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.38B $
Enterprise Value1.29B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-42.63M $
Revenue/Share—
Last Price14.92 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees121
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-28.32
PEG—
EV/EBITDA-26.50
EV/Revenue—
P/S—
P/B31.28
EPS (TTM)-1.04
EPS (Forward)-0.53
52W Range
14.4283% of range15.02
52W High15.02 USD
52W Low14.42 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.29%
ROA-40.35%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.68M $
CapEx (TTM)6.08M $
FCF Margin—
FCF Yield-1.47%
Net Debt-85.49M $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.18
Current Ratio11.09
Quick Ratio10.45
Book Value/Sh0.4770 USD
Cash/Share1.090 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.40 USD
Upside (mean)-3.5%
Target Range8.000 USD – 17.00 USD
$8.000-3.5% to mean$17.00
# Analysts5
Ownership
Shares Out.92.48M
Float64.10M
Insiders30.50%
Institutions8.94%
Short Interest
Short Ratio4.0d
Short % Float5.17%
Short % Out.3.55%
Shares Short3.21M
Short (prev mo.)2.21M
Technical
SMA 5012.36 (+20.7%)
SMA 2008.248 (+80.9%)
Beta1.19
S&P 52W Chg19.18%
Avg Vol (30d)561.74K
Avg Vol (10d)562.65K
Technical Indicators
RSI (14)66.5
MACD0.6693
MACD Signal0.5810
MACD Hist.+0.0883
BB Upper15.60 USD
BB Middle13.28 USD
BB Lower10.96 USD
BB Width34.92%
ATR (14)0.7467 USD
Vol Ratio (20d)1.09x